Northern Trust
NAMS icon

Northern Trust’s NewAmsterdam Pharma NAMS Stock Holding History

Northern Trust’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Buy
93,971
+61,753
+192% +$2.03M ﹤0.01% 2887
2026
Q1 		$1.03M Buy
32,218
+81
+0.3% +$2.64K ﹤0.01% 3331
2025
Q4 		$1.13M Sell
32,137
-1,162
-3% -$42.3K ﹤0.01% 3311
2025
Q3 		$947K Buy
33,299
+2,988
+10% +$71.6K ﹤0.01% 3428
2025
Q2 		$549K Buy
30,311
+651
+2% +$11.9K ﹤0.01% 3619
2025
Q1 		$607K Buy
29,660
+8,033
+37% +$179K ﹤0.01% 3495
2024
Q4 		$556K Buy
+21,627
New +$459K ﹤0.01% 3620

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Northern Trust's NAMS Position: Q2 2026 in Review

Northern Trust increased its NewAmsterdam Pharma (NAMS) stake by 192% in Q2 2026, buying an estimated $2.03M and bringing the position to 93,971 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2887.

Northern Trust first reported a position in NAMS in Q4 2024 and has held it in 7 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Northern Trust held 93,971 shares of NewAmsterdam Pharma worth $3.18M as of Q2 2026.
  • Northern Trust bought 61,753 NewAmsterdam Pharma shares in Q2 2026, an estimated $2.03M.
  • NewAmsterdam Pharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2887 holding.
  • Northern Trust first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 7 quarters since.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.